No Data
Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation
Geron Says Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Approval Of RYTELO (Imetelstat) For Treatment Of Adult Patients With Transfusion-dependent (TD) Anemia Due To Very Low, Low Or Intermediate Risk...
Express News | Geron Announces Positive Chmp Opinion for Rytelo™ (Imetelstat) for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk Mds
Stifel Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $8
Geron (GERN) Gets a Buy From Stifel Nicolaus
TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $10
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}